Advertisement
Confusing Signals From Centre, States On Plasma Therapy, Remdesivir?
Published On: September 29, 2020 | Duration: 12 MIN, 33 SEC
While Health Minister Harsh Vardhan has cautioned against "routine use" of plasma therapy and anti-viral drug Remdesivir to treat COVID-19 patients, stating the investigational therapies should be adopted "rationally", but states are continuing to push both therapies, especially in Delhi and Mumbai. We speak to Dr Sudarshan Ballal.
How Will Plasma Therapy Save Lives?
- Based on the concept of passive immunity
- Plasma contains components like blood cells, antibodies, protein, hormones etc. Infusing antibodies from a recovered patient will activate immunity in the patients
- Antibodies from donor plasma will be retained in blood for 2-3 weeks